Brexanolone as adjunctive therapy in super‐refractory status epilepticus

OBJECTIVE: Super‐refractory status epilepticus (SRSE) is a life‐threatening form of status epilepticus that continues or recurs despite 24 hours or more of anesthetic treatment. We conducted a multicenter, phase 1/2 study in SRSE patients to evaluate the safety and tolerability of brexanolone (USAN;...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosenthal, Eric S., Claassen, Jan, Wainwright, Mark S., Husain, Aatif M., Vaitkevicius, Henrikas, Raines, Shane, Hoffmann, Ethan, Colquhoun, Helen, Doherty, James J., Kanes, Stephen J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639357/
https://www.ncbi.nlm.nih.gov/pubmed/28779545
http://dx.doi.org/10.1002/ana.25008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639357/
https://www.ncbi.nlm.nih.gov/pubmed/28779545
http://dx.doi.org/10.1002/ana.25008

Ejemplares similares